Too Much PPI Use?
Proton-pump inhibitors (PPIs) are used for the long-termmanagement of gastroesophageal reflux disease (GERD).Originally approved for the treatment of erosive esophagitis,they also are commonly used to treat patients with nonerosivereflux disease. In a recent issue of Alimentary Pharmacologyand Therapeutics, Thomas J. Lee, MD, and colleaguesaddressed the potential overuse of these agents.Their review of the literature included observational studiesand randomized controlled trials that assessed the ability ofpatients'symptoms to be adequately controlled by lessaggressive PPI treatment.
A significant number of patients had adequate symptomcontrol when the daily PPI regimen was reduced in dosage(eg, 40 mg reduced to 20 mg) or when the dosage regimenwas changed from daily to intermittent (every other day) oron-demand treatment. Studies indicated that, once symptomswere controlled, PPI therapy could be substituted withhistamine H2A receptor antagonist therapy while maintaininga high degree of patient-reported satisfaction with efficacy.Physicians should consider the cost benefit and evaluatewhich of their GERD patients could be managed onreduced PPI therapy.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025